Compugen

Compugen

  • 560 S Winchester Blvd Ste 500
  • San Jose, California
  • 95128

Website Links

Description

Compugen, a genomics-based drug and diagnostic discovery company, increases the probability of successful development of novel drug and diagnostic products by incorporating ideas and methods from mathematics, computer science, and physics into the disciplines of biology, organic chemistry, and medicine. This unique capability results in powerful predictive models and discovery engines, which are both advancing the understanding of important biological phenomena and enabling the discovery of numerous potential therapeutic products and diagnostic markers. The Company has an early-stage in-house pipeline consisting of selected therapeutic protein candidates discovered by the Company; additional discoveries have been out-licensed for development. Among Compugen's customers and partners are leading pharmaceutical and diagnostic companies, such as Abbott Laboratories, Diagnostic Products Corporation, Novartis, and Pfizer.Compugen has been publicly traded on Nasdaq (NASDAQ: CGEN) since August 2000 and on the Tel Aviv Stock Exchange since January 2002. We have corporate offices in Israel, with a wholly owned subsidiary headquartered in California, and marketing and customer support presence in New Jersey and Maryland.Increasing the probability of success of new drug discovery is the single largest challenge facing the pharmaceutical industry today. This problem is a direct result of the lack of predictability in the drug discovery process, resulting in small yields and high costs. Unlike most life science organizations that rely largely on high throughput technologies to attempt to bypass this lack of predictability, Compugen is utilizing its unique integration of sophisticated mathematical modeling and experimental validation to gain deeper understandings of protein function and pharmaceutical and diagnostic utility. Using the predictive power of this infrastructure, we identify proteins with an increased probability of successfully functioning as therapeutics, drug targets, or diagnostic markers.

Products & services

Similar companies nearby